These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4440819)

  • 1. [Comparative study of the action of boric, benzene boronic and p-methyl-benzene boronic acids on the central nervous system].
    Pham-Huu-Chanh ; Sokan I; Quessada MH
    Agressologie; 1974; 15(1):61-72. PubMed ID: 4440819
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of the activity of boric, benzene-boronic and methyl-benzene-boronic acids upon respiration, general metabolism and systemic hemodynamics of the anesthetized dog.
    Pham-Huu-Chanh ; Sokhan I; Kan P
    Arzneimittelforschung; 1975 Jul; 25(7):1023-8. PubMed ID: 1174408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative effect of boric, benzene boronic and p-methylbenzene boronic acids on intestinal smooth muscle].
    Pham-Huu-Chanh ; Quessada MH; Sokan I
    Agressologie; 1974; 15(2):131-6. PubMed ID: 4447138
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 5. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis, pharmacological properties and effect upon monoamine oxidase activity of some sydnoneimines].
    Iashunskiĭ VG; Mashkovskiĭ MD; Gorkin VZ; Kholodov LE; Al'tshuler RA; Polezhaeva AI; Verevkina IV
    Farmakol Toksikol; 1970; 33(3):297-302. PubMed ID: 5453024
    [No Abstract]   [Full Text] [Related]  

  • 7. [Does potentiation of the excito-motor effects of tryptamine in the rat and mouse enable one to measure the action of monoamine oxidase inhibitors?].
    Denys A; Levy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):457-74. PubMed ID: 5850025
    [No Abstract]   [Full Text] [Related]  

  • 8. [Structure-action relations of monoamine oxidase inhibitors].
    Matthies H; Fähse C; Lietz W; Jassmann E
    Acta Biol Med Ger; 1967; 19(3):447-61. PubMed ID: 5591162
    [No Abstract]   [Full Text] [Related]  

  • 9. N-cyclopropyltryptamines, potent monoamine oxidase inhibitors.
    Winn M; Horrom BW; Rasmussen RR; Chappell EB; Plotnikoff NP
    J Med Chem; 1975 Apr; 18(4):437-8. PubMed ID: 1079054
    [No Abstract]   [Full Text] [Related]  

  • 10. [The central effect of benzidamine].
    Kuzina NV; Aleksandrova GM
    Farmakol Toksikol; 1972; 35(6):672-6. PubMed ID: 4651797
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologically active benzo (b)thiophene derivatives.
    Campaigne E; Knapp DR; Neiss ES; Bosin TR
    Adv Drug Res; 1970; 5():1-54. PubMed ID: 4395355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride].
    Gorkin VZ; Tochilkin AI; Andreeva NI; Mashkovskiĭ MD; Zhuravleva GV
    Farmakol Toksikol; 1974; 37(6):651-5. PubMed ID: 4464086
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological properties of some N-aroylhomotryptamines.
    Misztal S; Boksa J; Chojnacka-Wójcik E; Tatarczyńska E
    Pol J Pharmacol Pharm; 1979; 31(2):149-56. PubMed ID: 315061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological properties of alpha-phenyltetrahydrofuranone-2-gamma-carboxylic acid and its derivatives.
    Barczynska J
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):309-27. PubMed ID: 4738976
    [No Abstract]   [Full Text] [Related]  

  • 16. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract]   [Full Text] [Related]  

  • 17. Central nervous system depressant, analgesic and monoamine oxidase inhibitory properties of substituted piperidines.
    Pandey BR; Agrawal DK; Parmar SS; Willson WW; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):173-6. PubMed ID: 6701401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies on the brain mechanisms underlying two forms of behavioral excitation: stereotyped hyperactivity and "rage".
    Randrup A; Munkvad I
    Ann N Y Acad Sci; 1969 Jul; 159(3):928-38. PubMed ID: 4902868
    [No Abstract]   [Full Text] [Related]  

  • 19. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: The effect of psychotropic drugs on the dopa potentiation test in mice.
    Berendsen H; Leonard BE; Rigter H
    Br J Pharmacol; 1974 Nov; 52(3):432P-433P. PubMed ID: 4458854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.